Financial Performance
5Y price score: (55)
The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.
A score of 100 indicates that the stock did as well as the S&P 500 Index.
A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.
10Y return: (26.3)%
US$ Per
Share
By default your notes are visible only to you.
49.7
52-week range
79.3
Your model inputs
Your fair value & Margin of safety
To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.
Forecast:
Valuation
Free Cash Flow Yield
4.1 %
Dividend Yield TTM
4 %
Market cap $
$ 11,033
Price / Earnings TTM
37.2
Price / Book TTM
2.1
PEG TTM
0
Earnings growth and return
LTM
5YR
10YR
Total return (price & dividends)
10.7 %
(25.2) %
(26.3) %
Free cash flow per share growth
(12.9) %
(41.5) %
(16.5) %
Earnings per share growth
1,833.3 %
(68.6) %
(53.2) %
Founded: 1,970
Employees: 816
Business Summary:
Latest Earnings Call Takeaways
2026 Q2 (Jul 29, 2026)
1) Strong Operational and Financial Performance
- BXP reported FFO per share of $1.78, exceeding guidance and consensus by $0.08.
- The company raised the midpoint of its 2026 FFO per share guidance by $0.05.
- Leasing activity was robust, with 1.8 million square feet leased in Q2, 29% above the 10-year historical average.
- In-service portfolio occupancy increased to 88.4%, up from 87.4% in Q1 and 86.7% at the end of 2025.
2) Strategic Focus on Premier Workplaces and AI Demand
- BXP's strategy emphasizes leasing premier workplaces, particularly in gateway markets, which are outperforming the broader office market.
- The direct vacancy rate for premier workplaces is 8%, compared to 13.5% for the broader market, with asking rents commanding a 60% premium.
- The company is benefiting from increased demand from AI companies, with strong leasing activity in cities like San Francisco, New York, and Seattle.
3) Asset Sales and Capital Optimization
- BXP is ahead of schedule in its goal to generate $1.9 billion in net sale proceeds by 2028, having raised $370 million in 2026 and over $1.2 billion since the investor conference.
- Six assets are under contract for sale, expected to yield approximately $240 million in net proceeds.
- The company is exploring additional capital raising opportunities, with a healthy office sales market supporting its disposition strategy.
4) Development Pipeline and Future Growth
- BXP's development pipeline includes 3.5 million square feet of projects valued at $3.2 billion.
- The company successfully delivered 290 Binney Street, a 570,000-square-foot lab building, fully leased to AstraZeneca, ahead of schedule and under budget.
- The largest ongoing development is 343 Madison Avenue, with significant leasing progress and a construction loan of $1.2 billion secured.
5) Guidance and Market Outlook
- BXP raised its full-year 2026 FFO guidance to a range of $6.99 to $7.05 per share, reflecting strong leasing performance and improved occupancy expectations.
- The company anticipates cash same-store NOI to lag GAAP due to free-rent periods on new leases, with cash improvements expected in 2027.
- The transcript lacks specific details on the anticipated impact of asset sales on 2027 earnings and any potential stock buyback plans.
Bottom line: BXP's strong operational performance, strategic focus on premier workplaces, and proactive asset sales position the company well for continued growth, making it an attractive investment for shareholders.
Annual Reports, Presentations And IR Contacts
Go to the websiteBXP, Inc. — Financial Overview, Stock Price, Market Cap
BXP, Inc. is a company. Founded in 1970. As of August 14, 2026, the company's market capitalization is $11032645909 with a current stock price of $69.18.